Creo Medical has announced its first commercial orders for its lead Speedboat device. We see this as a significant milestone for the company, particularly as the order was received from the US, the largest healthcare market globally. This development maintains the strong momentum Creo Medical has delivered since it listed in 2016 and supports our expectation that the company will report its maiden revenues in FY19E. We maintain our Buy recommendation.
25 Jun 2019
Cenkos: Creo Medical Group Plc - First commercial sales
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc - First commercial sales
Creo Medical Group Plc (CREO:LON) | 34.5 0 0.0% | Mkt Cap: 124.7m
- Published:
25 Jun 2019 -
Author:
Chris Donnellan -
Pages:
5
Creo Medical has announced its first commercial orders for its lead Speedboat device. We see this as a significant milestone for the company, particularly as the order was received from the US, the largest healthcare market globally. This development maintains the strong momentum Creo Medical has delivered since it listed in 2016 and supports our expectation that the company will report its maiden revenues in FY19E. We maintain our Buy recommendation.